Stock NEUN NEUROGENESIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Neurogenesis, Inc.

Equities

NEUN

US64124F3010

Delayed OTC Markets
Other stock markets
 02:49:23 2024-06-12 pm EDT 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Neurogenesis, Inc. -.--% -.--%
2023 Neurogenesis, Inc. Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome CI
2021 Neurogene Inc. and University of Edinburgh Announces Research Collaboration to Advance Next Generation Gene Therapies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NEUROGENESIS, INC. Stock Neurogenesis, Inc.
 8.23K - - - - -
  1. Stock Market
  2. Equities
  3. NEUN Stock
  4. Charts Neurogenesis, Inc.
  5. Sector Chart